Stock listing

Glaxosmithkline S.a.e.

Selected listing: BIOC · EGX · EGP · EG

Glaxosmithkline S.a.e. (EGX:BIOC), Distribution Services. Latest release Jun 9, 2026: GSK’s $10.6B Nuvalent takeover fails to impress investors as shares…

BIOC:EGXEGPEGUpdated October 3, 2026
Glaxosmithkline S.a.e. logo
Ticker
EGX:BIOC
Asset type
Stock
Sector
Distribution Services
Industry
Medical Distributors
Exchange
EGX
Currency
EGP

About Glaxosmithkline S.a.e.

Glaxosmithkline S.a.e. is a public company traded under the ticker BIOC in the Egyptian market. It operates in the pharmaceutical sector, focusing on the development and distribution of healthcare products.

Latest news from Glaxosmithkline S.a.e.

GSK’s $10.6B Nuvalent takeover fails to impress investors as shares fall: here's why

June 9, 2026

Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation

May 5, 2026

Glaxosmithkline Q3 Consol Loss EGP 34.8 Million

November 13, 2025

All Glaxosmithkline S.a.e. news →

Research Glaxosmithkline S.a.e.

Glaxosmithkline S.a.e. company profile

View the public company page for Glaxosmithkline S.a.e. on 6ix.

Glaxosmithkline S.a.e. news

Read company news and market updates connected to Glaxosmithkline S.a.e..

Glaxosmithkline S.a.e. investor events

Find investor webinars, events, and replay context for Glaxosmithkline S.a.e..